Our observation of elevated CSF CXCL13 in CIS is in line with previous studies that found CXCL13 to be elevated in CSF and serum across different subtypes of MS as well as in CIS [11], [12], [27], [28]. The gene discussed is CXCL13; the disease is in situ carcinoma.